Skip to main content
Full access
Communications and Updates
Published Online: 1 November 2010

Questions on Conflict of Interest

To the Editor: We are writing to inquire about how the Journal handles issues of conflict of interest, both financial and intellectual. We raise these questions in the interest of stimulating discussion and encouraging greater transparency, not because we believe there is necessarily one right answer to any question.
What is the operational basis of the Editor's evaluation for possible influence from disclosed financial relationships? Given that such influences can be difficult for nonspecialists to detect and may operate beyond the awareness of authors themselves, what criteria are used to judge whether influence has occurred?
1) Is potential conflict of interest one of the criteria taken into account when inviting authors of editorials or review articles? For example, if faced with a choice of several possible authors, does the Journal give preference to those without potential conflicts of interest, all other factors being equal?
2) Does the Journal's conflict of interest policy take into account so-called intellectual conflict of interest as well as financial conflict of interest? Some professional societies are beginning to pay attention to this type of conflict in relationship to practice guidelines (1).
Restrictions on authorship have costs of their own, including exclusion of the contributions of experts in a field, and should not be undertaken lightly. However, the argument for preferring authors without financial relationships with industry seems particularly strong in the case of editorials and reviews, the value of which resides principally in the reliance that readers can place on the opinions of the authors. Advocating norms of this sort is not to suggest that industry relationships are necessarily problematic in themselves, but recognizes that certain activities may be incompatible with playing an active role in developing treatment recommendations for the field, as is the case for the development of DSM-5 (2).

Footnote

accepted for publication in August 2010.

References

1.
Guyatt G, Akl EA, Hirsh J, Kearon C, Crowther M, Gutterman D, Lewis SZ, Nathanson I, Jaeschke R, Schunemann H: The vexing problem of guidelines and conflict of interest: a potential solution. Ann Intern Med 2010; 152:738–741

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 1407
PubMed: 21041256

History

Accepted: August 2010
Published online: 1 November 2010
Published in print: November 2010

Authors

Affiliations

David A. Gorelick, M.D., PH.D.
Paul S. Appelbaum, M.D.

Funding Information

Dr. Gorelick is supported by the Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health. Dr. Appelbaum has an equity interest in COVR, Inc.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share